Expert Consensus
Multidisciplinary international expert consensus on perioperative airway management
Translational Lung Cancer Research
2025;
14
(4)
:1042-1060
.
(30 April 2025)
Original Article
Deep learning model for predicting spread through air spaces of lung adenocarcinoma based on transfer learning mechanism
Translational Lung Cancer Research
2025;
14
(4)
:1061-1075
.
(30 April 2025)
Integrating radiomics and deep learning for enhanced prediction of high-grade patterns in stage IA lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(4)
:1076-1088
.
(30 April 2025)
DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy
Translational Lung Cancer Research
2025;
14
(4)
:1089-1103
.
(30 April 2025)
Using human genetics to understand the epidemiological association between neuroticism and lung cancer
Translational Lung Cancer Research
2025;
14
(4)
:1104-1117
.
(30 April 2025)
Development and validation of machine learning models based on molecular features for estimating the probability of multiple primary lung carcinoma versus intrapulmonary metastasis in patients presenting multiple non-small cell lung cancers
Translational Lung Cancer Research
2025;
14
(4)
:1118-1137
.
(30 April 2025)
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion
Translational Lung Cancer Research
2025;
14
(4)
:1138-1148
.
(30 April 2025)
Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy
Translational Lung Cancer Research
2025;
14
(4)
:1149-1157
.
(30 April 2025)
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study
Translational Lung Cancer Research
2025;
14
(4)
:1158-1167
.
(30 April 2025)
Integrative radiomics analysis of peri-tumoral and habitat zones for predicting major pathological response to neoadjuvant immunotherapy and chemotherapy in non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(4)
:1168-1184
.
(30 April 2025)
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan
Translational Lung Cancer Research
2025;
14
(4)
:1185-1196
.
(30 April 2025)
Diagnostic accuracy of serum biomarkers MMP11 and SPP1 in non-small cell lung cancer: an analysis of sensitivity, specificity, and area under the curve
Translational Lung Cancer Research
2025;
14
(4)
:1197-1211
.
(30 April 2025)
Comparing neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil count (ANC) and derived NLR as predictive biomarkers in first-line immunotherapy for non-small cell lung cancer: a retrospective study
Translational Lung Cancer Research
2025;
14
(4)
:1212-1230
.
(30 April 2025)
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial
Translational Lung Cancer Research
2025;
14
(4)
:1231-1241
.
(30 April 2025)
Metabolic tumor volume on 18F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(4)
:1242-1253
.
(30 April 2025)
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study
Translational Lung Cancer Research
2025;
14
(4)
:1254-1265
.
(30 April 2025)
Tracheobronchial resection and reconstruction: to wrap or not to wrap the anastomosis?
Translational Lung Cancer Research
2025;
14
(4)
:1266-1273
.
(30 April 2025)
Uniportal video-assisted thoracoscopic surgery does not increase recurrence rates following pneumonectomy in non-small cell lung cancer: a retrospective study from the National Cancer Center of China
Translational Lung Cancer Research
2025;
14
(4)
:1274-1289
.
(30 April 2025)
Budesonide/glycopyrronium/formoterol fumarate co-suspension metered dose inhaler relieves cough after lobectomy: a randomized controlled study
Translational Lung Cancer Research
2025;
14
(4)
:1290-1300
.
(30 April 2025)
Characterization of the xeno-GVHD response generated by advanced lung cancer patient peripheral blood mononuclear cells in NSG-SGM3 mice
Translational Lung Cancer Research
2025;
14
(4)
:1301-1319
.
(30 April 2025)
FOXO3a regulation of non-small cell lung cancer radiotherapy resistance through the PINK1/Parkin pathway of protective mitophagy
Translational Lung Cancer Research
2025;
14
(4)
:1320-1339
.
(30 April 2025)
Predictive value of the monocyte-to-high-density lipoprotein ratio in the prognosis of non-small cell lung cancer patients after surgery
Translational Lung Cancer Research
2025;
14
(4)
:1340-1350
.
(30 April 2025)
LNCAROD was stabilized through N6-methyladenosine methylation and exerted its anticancer effects in lung squamous cell carcinoma by inhibiting SIRT1 activity via CCAR2
Translational Lung Cancer Research
2025;
14
(4)
:1351-1370
.
(30 April 2025)
Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy
Translational Lung Cancer Research
2025;
14
(4)
:1371-1383
.
(30 April 2025)
Clinical implication of tumor spread through air spaces in stage IA lung adenocarcinoma: prognostic impact and association with the International Association for the Study of Lung Cancer (IASLC) grade
Translational Lung Cancer Research
2025;
14
(4)
:1384-1394
.
(30 April 2025)
Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study
Translational Lung Cancer Research
2025;
14
(4)
:1395-1407
.
(30 April 2025)
Effect of the number of induction chemotherapy cycles on the efficacy of first-line atezolizumab combined with chemotherapy in extensive-stage small cell lung cancer
Translational Lung Cancer Research
2025;
14
(4)
:1408-1417
.
(30 April 2025)
Nanoassemblies loaded with low-dose paclitaxel can enhance the response of lung cancer immunotherapy by activating dendritic cells
Translational Lung Cancer Research
2025;
14
(4)
:1418-1440
.
(30 April 2025)
Review Article
Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature
Translational Lung Cancer Research
2025;
14
(4)
:1441-1455
.
(30 April 2025)
SMARCA4 deficiency: implications for non-small cell lung cancer and management strategies, with relevance to and distinctions from thoracic undifferentiated tumor
Translational Lung Cancer Research
2025;
14
(4)
:1456-1470
.
(30 April 2025)
A narrative review of preoperative CT for predicting spread through air spaces of lung cancer
Translational Lung Cancer Research
2025;
14
(4)
:1471-1481
.
(30 April 2025)
Comprehensive management of MET tyrosine kinase inhibitor-induced peripheral edema in patients with MET-altered non-small-cell lung cancer: a narrative review
Translational Lung Cancer Research
2025;
14
(4)
:1482-1495
.
(30 April 2025)
